RMD News: QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus - 15th May 2024, 12:08am

[annb0t]

QIAGEN N.V. QGEN recently secured FDA clearance for the QIAstat-Dx Respiratory Panel Plus syndromic test. Previously authorized under the FDA Emergency Use Authorization (“EUA”) as the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the test is designed to support clinical decision-making in diagnosing upper respiratory infections and covers 21 viral and bacterial targets.

The latest development will strongly boost the company’s Molecular Diagnostics business.

Significance of the QIAst...

>>> Read more: QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus